about
Current status of cranial stereotactic radiosurgery in the UKVolumetric modulated arc therapy: a review of current literature and clinical use in practice.Direct detection of 6 MV x-rays from a medical linear accelerator using a semiconducting polymer diode.Cardiac exposures in breast cancer radiotherapy: 1950s-1990s.Establishing the suitability of quantitative optical CT microscopy of PRESAGE® radiochromic dosimeters for the verification of synchrotron microbeam therapy.Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001.A multicentre 'end to end' dosimetry audit for cervix HDR brachytherapy treatment.Dosimetric audit in brachytherapy.The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignanciesFeasibility of using glass-bead thermoluminescent dosimeters for radiotherapy treatment plan verification.Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.A survey of quality control practices for high dose rate (HDR) and pulsed dose rate (PDR) brachytherapy in the United Kingdom.Review of doped silica glass optical fibre: their TL properties and potential applications in radiation therapy dosimetry.The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning.Factors influencing the robustness of P-value measurements in CT texture prognosis studies.Challenges in calculation of the gamma index in radiotherapy - Towards good practice.Changes in Patterns of Intensity-modulated Radiotherapy Verification and Quality Assurance in the UK.Mathematical modelling of tumour volume dynamics in response to stereotactic ablative radiotherapy for non-small cell lung cancer.Can CT scan protocols used for radiotherapy treatment planning be adjusted to optimize image quality and patient dose? A systematic review.Clinical validation and benchmarking of knowledge-based IMRT and VMAT treatment planning in pelvic anatomy.Simulation of tissue activity curves of (64)Cu-ATSM for sub-target volume delineation in radiotherapy.Risk of ischemic heart disease in women after radiotherapy for breast cancer.A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems.Comparison of methods for the measurement of radiation dose distributions in high dose rate (HDR) brachytherapy: Ge-doped optical fiber, EBT3 Gafchromic film, and PRESAGE® radiochromic plastic.A methodology for dosimetry audit of rotational radiotherapy using a commercial detector array.Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for ¹⁸F-FDG-PET-guided dose escalation in oropharyngeal cancer: a planning study.Dosimetric verification of a commercial collapsed cone algorithm in simulated clinical situations.Dosimetry of the microSelectron-HDR Ir-192 source using PRESAGE and optical CT.Evaluating commercial image registration packages for radiotherapy treatment planning.Clinical applications of textural analysis in non-small cell lung cancer.Adaptation and validation of a commercial head phantom for cranial radiosurgery dosimetry end-to-end audit.Editorial: The role of medical physics in lung SBRT.Design concept for a novel SQUID-based microdosemeter.Adapting clinical gamma cameras for body monitoring in the event of a large-scale radiological incident.Evaluation and mitigation of potential errors in radiochromic film dosimetry due to film curvature at scanning.A comparison of protocols for external beam radiotherapy beam calibrations.Evaluation of Gafchromic EBT-XD film, with comparison to EBT3 film, and application in high dose radiotherapy verification.A multi-institutional dosimetry audit of rotational intensity-modulated radiotherapy.Polarity and ion recombination correction factors for ionization chambers employed in electron beam dosimetry.Evaluation and implementation of triple-channel radiochromic film dosimetry in brachytherapy.
P50
Q30364393-6947B9A1-78BD-4992-870C-0248D5A313D2Q30461426-65AE3836-145A-4AC8-B32F-34BAC2CA74E4Q30646741-6E2A4DD3-052C-4D18-9D10-F4D142FD0953Q34717876-2F166582-1557-4277-B46A-D87BD030A50FQ34961177-0986986C-A7BB-4A01-BD5C-BA142BAC9E11Q35201528-F5DE5009-5E3F-44C1-8AB2-182529F6D41AQ35542030-00E9D92D-CF09-4454-A128-65FF5F2F010FQ35676713-59E02055-D4DF-4550-B85C-4E9ED2EEC98BQ36364402-7323FAE3-2401-473B-B1AB-9CC42FAE0DDBQ36550506-22538842-50D9-448F-94F1-65D16696824EQ36550547-9A1E8743-B044-4391-BD9A-6D5B9A70299DQ36579728-0ECCF375-DF8A-4230-BA30-CC7BCD342C29Q37989705-BAEA2041-92DE-4EAB-B3F5-1B70529E4FC1Q38232757-C4152D53-BA0D-4310-B278-16B958904D7BQ38730653-11CBBF4B-2CD5-406B-A6B4-8CFE7BFADD6EQ38836498-70562CCC-0804-4317-90A5-335D0828C922Q38907887-6B3B5D45-12F6-4A14-9A22-5D996DBA5050Q39017108-1E53F95D-D057-4EA4-93B3-851D337BF14AQ39269304-392B8427-737F-4C15-9647-C8021EEE2EE3Q39592463-7850C96D-E916-4204-8E4B-4D258E7BD326Q43195158-A6393C49-ED79-4826-855D-4555C9BD6959Q43615460-A2E8C739-CAC2-44BD-9C19-B7636351F824Q43723611-D133D5F4-E35C-4071-8BA7-DF531D90F6B4Q43913936-AFF93E01-681B-4537-B360-7BD7DE92AFFEQ44011115-FF223407-BF8A-4678-8521-C4E496663E74Q45007224-F23A9A1B-AE3E-4C18-B370-AC2F3CF8E596Q45090467-38B3CF12-5655-484D-A86B-04C22200AB03Q47412069-3B3C2EFF-2905-431C-B7F7-222B9367AF31Q47430280-EF1C70E0-C7B4-4584-9D72-9E5DEE7E4BA1Q47966288-9E8086D9-38EB-46F7-A6E0-15B686CA7B2EQ48219011-55D8B07A-3BE2-428A-96F3-A741E9755F76Q50080106-18A8F61F-F74B-4F1F-A60D-8AEA9CE4DD75Q50550572-E5826A86-A2FE-4B09-8387-DF0D815B259DQ50631923-418468DD-4FDB-4C53-97E5-1F015A1C8D5BQ50894073-5BF08115-9753-415E-8BE0-4758D0A854DAQ50943890-4BEC6188-A785-4B91-9808-95BC5DA8FB04Q51667407-C3271B6F-F40D-4997-96FF-C54B23CAFCF7Q53371465-D11C1560-DF5E-49A8-9103-64C979E77DF2Q53925666-794EB48F-12BB-48F2-BFB3-E6552069D6B5Q55270876-DD6CBDE6-8806-446F-AEA4-9413A6B2F1F2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrew Nisbet
@ast
Andrew Nisbet
@en
Andrew Nisbet
@es
Andrew Nisbet
@nl
type
label
Andrew Nisbet
@ast
Andrew Nisbet
@en
Andrew Nisbet
@es
Andrew Nisbet
@nl
prefLabel
Andrew Nisbet
@ast
Andrew Nisbet
@en
Andrew Nisbet
@es
Andrew Nisbet
@nl
P106
P31
P496
0000-0002-0652-808X